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The complexity of mammalian development is intrinsic 
to the zygote with genes encoding the information 
necessary for every tissue and cellular sub-type.   
Development initiates with totipotent embryonic stem 
cells (ESCs), which give rise to the three germ layers, 
the ectoderm, the mesoderm and the endoderm, 
eventually constructing the tissues of the body.  ESCs 
possess characteristics such as asymmetric cellular 
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the  past  century.  With  improving  health  care  in  the  developed  world  there  is  a  proportional  augmentation  in  the
treatment necessary for elderly patients occasioning the call for increased research in the area of aging and age‐related








layers, telomerase activity, and a cell cycle that has 
significantly diminished gap phases.  In adulthood, 
multipotent tissue specific stem cells regulate homeo-
static tissue regeneration.  These adult stem cells (ASCs) 
while lacking the capacity to differentiate into the three 
germ layers are capable of regenerating a cellular popula-
tion of a specific tissue type and maintain asymmetric 
cellular division.  ASCs are characterized as being in a 
state of relative proliferative quiescence, which they can 
exit from under the proper conditions, to obtain the 
proliferative potential necessary for tissue regeneration.  
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structure; they accomplish this through their functional 
duality between self-renewal and commitment.  The 
tissue specific ASC populations are vital to survival and 
therefore must be maintained through self-renewal.  
However, the necessity for self-renewal must be 
transient, as the cells are also required to differentiate 
and commit to a specific lineage.  The balance between 
self-renewal and commitment is critical.  If the ASC 
population leans towards the self-renewal pathway, it 
risks the loss of differentiation capacity and could 
malignantly transform into a highly proliferative non-
differentiating cellular population.  On the other hand, if 
the balance shifts towards differentiation, there is a risk 
that the stem cell population would be lost accompanied 
by an increased potential for degenerative disease 
occurrence, a mechanism that is believed to be a 
component of the aging process.  
 
Organismal aging and age-related diseases are often 
associated with senescence. Hayflick originally 
described senescence as a permanent cell cycle arrest 
due to the limited replicative potential of cultured 
human fibroblasts [1].  Telomere shortening, oncogene 
activation or DNA damaging events can trigger the 
senescence pathway.  Senescence plays a critical role in 
maintaining properly functioning ASC populations.   
Under normal conditions ASCs divide to replace aging 
tissue. During lifetime, extrinsic sources (such as 
ionizing radiation, genotoxic drugs, chemicals, etc.) and 
intrinsic factors (DNA replication errors, spontaneous 
chemical changes to DNA, programmed DNA 
recombination) can lead to mutations, which could 
accumulate over time in the progenitor population. 
 
Regeneration can also be triggered due to tissue 
damaging events, which could directly expose the ASC 
population to mutations and/or alter the regulatory 
tissue microenvironment.  Stem cells possess inherent 
damage repair mechanisms that can respond to DNA-
damage, reactive oxygen species (ROS) damage and 
mutations that de-regulate the cell-cycle and other 
cellular functions.  When these repair mechanisms fail 
the cell will accrue increased levels of damage, 
initiating cell-death pathways such as senescence or 
apoptosis (programmed cell death). The depletion of the 
progenitor cell population results in an inability for 
tissue renewal, aging and possible development of 
degenerative diseases.  On the other side, failing to 
properly repair DNA damage along with escape from 
apoptosis and/or senescence could trigger neoplastic 
transformation of stem cells. 
 
Stem cells encapsulate such an immense clinical 
therapeutic potential that understanding their intricate 
biological role is paramount.  Unfortunately, the 
definition of stem cells remains to be nebulous and data 
can be contradictory.  In this review we will attempt to 
describe stem cell properties in both embryonic and 
adult stem cells and the intriguing regulation of the cell 
cycle in these systems.  We then discuss the role of the 
senescence process in ASCs and its relation to aging 
and age-related diseases.  Concluding, we will examine 
how the de-regulation of the mechanisms discussed may 
lead to carcinogenesis and what stem cell research may 
hold for future therapeutic prospects. 
 
Embryonic Stem Cells and Their Origins 
 
Thomson and Gearhart are attributed with initial 
isolation and characterization of human ESCs (hESCs) 
from the inner cell mass of the blastocyst, noting the 
differentiation and self-renewing capacity of the cells in 
vitro [2, 3].  Further characterization demonstrated that 
the cells expressed cell surface markers typical of 
undifferentiated nonhuman primate ESCs (pESCs) and 
human embryonic carcinoma cells as was originally 
described [2, 3, 4, 5].  These specific markers included 
stage-specific embryonic antigen (SSEA)-1, SSEA-3, 
SSEA-4, TRA-1-60, TRA-1-81, alkaline phosphatase 
activity and high levels of telomerase activity [2, 3].   
Telomerase is a ribonucleoprotein enzyme that 
preserves the telomeric regions at the ends of 
chromosomes by de novo oligonucleotide synthesis [6].  
Telomerase activity is not present in normal diploid 
somatic cells, which incur shorted telomeres with age 
leading to replicative senescence after a finite number 
of replications [1, 7, 8, 9].  It has been shown that TRA-
1-60 and TRA-1-81 are specific epitopes of a larger 
membrane-bound protein podocalyxin, which under-
goes retinoic acid modification when ESCs differentiate 
losing its reactivity with the TRA-1-60 and TRA-1-81 
antibodies [10].  These characterizations remain to be 
used to identify stem cells today, along with the 
expression of the intrinsic transcription factor Oct-4 and 
in mouse ESCs (mESCs) the constitutive ability to 
receive extrinsic signals from the cytokine leukemia 
inhibitory factor (LIF) [11, 12, 13].  
 
Soon after the initial isolations and characterizations of 
hESCs, interest shifted towards understanding the 
factors involved in their differentiation. For example, if 
all cells are derived from initial progenitor cells, what 
directs differentiation towards glial cells versus 
adipocytes?  Brüstle et al were among the first to 
demonstrate in vitro controlled differentiation of hESCs 
using a series of growth factor combinations, which 
successfully elicited a reactivity to a monoclonal 
antibody specific for a membrane epitope typically 
found on the membranes of glial precursors [14].  They 
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growth of neural precursors.  They then exposed cells to 
the following series of growth factors: i) basic fibroblast 
growth factor (FGF2), ii) FGF2 and epidermal growth 
factor (EGF) and iii) FGF2 and platelet-derived growth 
factor (PDGF) [14].  The cells maintained in the final 
growth factor-supplemented media were able to be 
stored and kept in culture without further differentiation 
for many passages.  However, as growth factors were 
removed cells further differentiated into more specific 
neural cell types such as oligodendrocytes and 
astrocytes [14].  The cells that were preferentially 
differentiated were injected into a rat model of a human 
hereditary myelin disorder, Pelizaeus-Marzbacher 
disease, and effectively remyelinated the axons of the 
brain and spinal chord [14].  These results as well as 
others [15, 16] demonstrated the potential to manipulate 
the differentiation of isolated hESCs in vitro for 
therapeutic treatment of human disease.   
 
Embryonic Stem Cells and Their Regulation of the 
Cell Cycle 
 
A major difference between stem cells and somatic cells 
is found in the basic regulation of the cell cycle.  In 
somatic cells the cell cycle is controlled mainly by Rb-
E2F family complexes, cyclin-cyclin dependent kinases 
(Cdks), and Cdk inhibitors through the INK4a/ARF 
pathway.  Undulations in expression and post-
translational modifications of the proteins involved in 
these pathways result in the control and regulation of 
the cell cycle.  Likewise, mutations or de-regulation of 
these proteins can lead to uncontrolled cell proliferation, 
aneuploidy, and genomic instability [17, 18].   
 
The cell cycle regulatory mechanisms, which differ 
between somatic cells and ESCs have been determined 
using the mESC model in combination with mESCs 
representing a pluripotent lineage (mEPLC) [19].   
mESCs of late pre-implantation and early post-
implantation embryos proliferate at an unusually rapid 
rate [20].  Between 4.5 and 6.0 dpc (days post coitum), 
the epiblast expands with a generation time of 
approximately 10 hours [21].  This increases between 
6.5 and 7.0 dpc, where mean generation times are found 
to be approximately 4.4 hours [21, 22].  The cell cycle 
in mESCs and mEPLCs has been found to curtail G1 
and G2 phases with an increased proportion of the 
cycle, approximately 50-60%, spent in S phase [23, 24].  
 
Under normal somatic cell cycle conditons, Rb/p105, in 
the hypophosphorylated state, interacts with E2F 
transcription factors inhibiting the transcription of genes 
necessary for the progression of the cell cycle through 
the restriction point (R point).  The phosphorylation 
levels of Rb/p105 are dependent upon the CDK activity 
present in the cell.  Mitogen signaling through the 
Ras/Raf/mitogen activated protein kinase (MAPK) 
pathway activates the cyclin D - CDK4/6 complexes, 
which are believed to initially activate Rb/p105 activity 
by hypophosphorylating the unphosphorylated protein.  
To pass the R point of the cell cycle cyclin E/CDK2 
hyperphosphorylates Rb/p105 inhibiting the protein 
from binding to E2F transcription factors thus initiating 
the transcription of genes required in the S phase of the 
cell cycle.  To obtain a cell cycle that is less influenced 
by mitogen variations, stem cells appear to adopt a 
different regulation mechanism as depicted in Figure 1 
[25, 26]. 
 
Along with shortened gap phases in the ESC cell cycle, 
the R point does not seem to regulate the G1 – S 
transition. Stead and collegues found that in both 
mESCs and mEPLCs there was a precocious cell cycle-
independent expression of CDK2, cyclin A and cyclin E 
kinase activity [24].  Furthermore, when CDK2 was 
suppressed they found a significant decrease in cell 
proliferation rate.  Instead CDC2 – cyclin B, essential to 
G2 – M transition, was the only CDK activity that was 
found to be cell cycle-dependent and E2F target genes 
were constitutively expressed throughout the cell cycle 
[24].  Evidence has also shown a lack in hypo-
phosphorylated Rb/p105, instead findings support the 
presence of hyperphosphorylated Rb/p105 in mESCs 
and mEPLCs [23, 27].  Given the cell-cycle indepen-
dent expression of cyclin E and CDK2, it would be 
logical that Rb/p105 would be found in the 
hyperphosphorylated state, further supporting the 
absence of the R point in ESC cell cycle progression 
(Figure 1).   
 
Mitogen signaling through the MAPK pathway 
normally stimulates cell division in somatic cells, 
however, this signaling when prolonged is a potent 
inducer of differentiation.  mESCs appear to avoid this 
stimulation by maintaining low levels of cyclin D 
expression and almost no detectable CDK4 kinase 
activity [28].  This corresponds to the lack in 
hypophosphorylated Rb/p105 levels previously detected 
in mESCs.  These findings support the absence of early 
G1 in mESCs, allowing them to avoid the 
differentiation-inducing effects of MAPK signaling as is 
found in other cell types.  
 
Although the majority of studies thus far have been 
performed in mESCs, hESCs similarly show a 
truncation of the G1 phase of the cell cycle, however 
not much else is known about cell cycle regulation in 
hESCs.  Interestingly, primate ESCs behave similarly to 
mESCs in having cell cycle-independent expression of 
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and serum and MAPK-independent cell cycle 
progression [28, 29].  Therefore, it could be inferred 
that through conserved evolution hESCs may regulate 
the cell cycle in a similar fashion. Taken together these 
data lead to the hypothesis that the ESC cell cycle is 
rate-dependent upon high levels of CDK activity, is not 
regulated by Rb/p105 or E2F gene expression, lacks the 
G1 check point and the traditional periodicity found 
during the somatic cell cycle. 
 
Adult Stem Cell Characteristics 
 
The first evidences of adult stem cells were described as 
lympho-haematopoietic stem cells, which were capable 







































[30].  The previous medical studies, showing the 
capability of bone marrow to regenerate a transplanted 
patient’s bone marrow attributed credibility to these 
finding [31].  Presently, adult stem cell tissue rege-
neration is not a foreign concept and it is well accepted as 
the regenerative mechanism in tissues such as the 
intestinal epithelium, bone marrow, and skin.  The almost 
constant regeneration of these tissues has been linked to 
tissue specific adult stem cell populations, which when 
deregulated have been associated with various diseases 
and cancers [32, 33, 34, 35].  While these were the most 
physiologically obvious tissues in which stem cell 
regeneration could occur, adult stem cell populations 
have also been identified and characterized in the retina 
[36], the pancreas [37], the liver [38], the central nervous 
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haematopoietic and mesenchymal stem cells (HSCs and 
MSCs).  HSCs are the progenitor lineage that produces 
all of the mature blood cells throughout an organism’s 
life.  It was originally noted that the HSC population 
contained two populations of stem cells, which 
responded differently to radiation [41].  The cycling 
population was unable to repair DNA-damage and 
produced acute marrow failure, whereas the more 
primitive quiescent population appeared to repair 
radiation induced damage [41].  These findings have 
been further supported and outline the classification of 
HSCs into the two following groups: the long-term 
repopulating HSCs (LTR-HSCs), primarily found in a 
quiescent state, and the short-term repopulating HSCs 
(STR-HSCs), which undergo haematopoiesis supplying 
the daily replenishment of mature blood cells. This 
mechanism that HSCs have adopted has allowed the 
progenitor population of LTR-HSCs to maintain 
genomic integrity by reduced replication events [42].   
MSCs are a cellular population found in the bone 
marrow alongside the HSCs, which differentiate into 
cells of the mesenchymal lineage including bone, 
cartilage, fat, connective tissue, muscle and marrow 
stroma [43, 44].  The MSC population is quite hetero-
geneous and more recently multiple pre-MSC lineages 
have been described: MAPC, hBMSC, USSC, FSSC, 
AFS, MIAMI cells, hFLMPC, and MASC [45, 46, 47, 
48, 49, 50, 51, 52].  Pre-MSCs have been shown to 
differentiate and form the three germinal layers, 
furthermore multiple lineages have been shown to 
proliferate without telomere shortening [42].  These 
lineages speak to the complexity of the regenerative 
mechanism that still has yet to be well defined. 
 
Aside from haematopoietic and mesenchymal stem cells 
(HSCs and MSCs) the identified adult stem cell 
populations have been onerous to study, due to the 
difficulty in isolating and culturing the cells in vitro 
[35].  Since their discovery, it has been understood that 
adult stem cells reside in niches that supply the cells 
with necessary growth factors and stimulation to 
undergo self-renewal and proliferation [53, 54].  When 
these growth factors are applied to in vitro culture 
conditions, viable adult stem cell culture has been 
achieved [55, 56, 57, 58, 59, 60].  However, there is still 
restricted understanding of these adult stem cell 
populations and their properties. 
 
Genomic studies, utilizing microarray technology, have 
identified molecular signatures for specific and across 
diverse populations of stem cells [61, 62, 63].   
Particular genes were found to span both ESCs as well 
as diverse adult stem cell lineages.  These studies 
concluded that while many of these genes were 
ubiquitously expressed in other tissues, a subset of this 
grouping could represent genes involved in general 
stem cell growth and maintenance [35].  More recently, 
Rossi et al. using an oligonucleotide microarray, 
identified 907 out of 34,000 genes that were 
significantly differentially expressed between HSCs 
from young and old mice, sixteen of the genes more 
highly expressed in older animals have been implicated 
in human leukemia.  [64, 65, 66].  A similar study found 
that genes of the functional categories DNA repair, 
chromatin remodeling, and silencing genes were 
expressed less in HSCs from aged animals.  These 
findings may suggest genetic and epigenetic alterations 
that are responsible for the differences observed 
between young and old HSCs.   
 
Adult Stem Cells and Their Regulation of the Cell 
Cycle 
 
Adult stem cells, differing from ES cells, maintain a 
quiescent state in vivo unless they are stimulated by 
tissue damage or regenerative signals to differentiate.   
In normally dividing cells entering into the quiescent 
state there is an upregulation of CDK inhibitors, which 
act to block the kinase activity of CDKs effectively 
blocking cell proliferation [67, 68, 69, 70, 71].  Further-
more, CDK inhibitor expression is independently 
sufficient to inhibit proliferation [67].  CDK inhibitor 
expression is found in quiescent ASCs and when 
downregulated can initiate proliferation and 
differentiation in HSCs [72, 73, 74].   
 
Unfortunately, due to the limitations in the data that are 
currently available, it is not possible to construct a 
detailed ASC cell cycle model.  From what has been 
gleaned of the ESC model, it is believed that the G1 
phase and the R point are critical in the decision 
between self-renewal and differentiation, as well as the 
directionality of differentiation.  Much of the data 
seems to suggest that the mechanisms regulating the cell 
cycle are extrinsically supplied from the cellular 
microenvironment, the niche.  However, more studies 
will be needed before we can truly understand the roles 
of the regulatory protein mechanisms recognized for so 
long as the classical cell cycle model. 
 
Aging and Maintenance of Adult Stem Cells 
 
Self-renewal of stem cells is critical for their persistence 
through life, however the capacity to maintain this 
characteristic declines with age [75, 76].  The decline in 
the maintenance of the self-renewal pathway is 
considered one of the major mechanisms attributing to 
aging.  p16
Ink4a, a cyclin-dependent kinase inhibitor, 
promotes Rb/p105 activation and is associated with the 
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recently been ascribed to stem cell aging and loss in 
self-renewing properties [75, 78].  In fetal stem cell 
populations there is no detectable expression of p16
Ink4a, 
however increasing levels of p16
Ink4a expression have 
been detected in stem cells of aging tissues [76, 79].   
 
The  INK4a/ARF tumor suppressor locus encodes for 
p16
Ink4a and p19
Arf, which act respectively through the 
Rb and p53 cell death pathways [80].  The INK4a/ARF 
locus is activated in tissues under oncogenic stresses, 
such as DNA damage and telomere shortening.  p16
Ink4a 
then acts to inhibit the kinase activities of cyclin D1 – 
CDK4, cyclin D2 – CDK4, and cyclin D3 – CDK6.  D-
type cyclin and CDK complexes phosphorylate 
Rb/p105, when in the hypophosphorylated form 
Rb/p105 binds to E2F-1, 2, 3, and 4 blocking their 
activity as transcriptional activators.  E2F target genes 
are required for progression of the cell cycle and their 
transcriptional repression results in G1 cell cycle arrest 
and eventual replicative senescence.  p19
Arf interacts 
with p53 initiating p53-dependent cell death, or 
apoptosis.  p19
Arf can also slow the cell cycle and lead 
to senescence.  Similar to p16
Ink4a, p19
Arf is not 
expressed in fetal stem cells but is found to increase in 
aging stem cells [76, 79]. 
 
To maintain their replicative and self-renewing potential 
stem cells have in place mechanisms to repress 
activation of cell death pathways.  Bmi-1 has been 
shown to promote self-renewal in stem cells by 
repressing the expression of p16
Ink4a and p19
Arf through 
negative regulation of the INK4a/ARF locus (Figure 2).  
In  Bmi-1
-/- neural stem cells, Molofsky and collegues 
found overexpression of p16
Ink4a and reduced rates of 
proliferation [81, 82].  Park and collegues determined 
that Bmi-1 is essential for the self-renewal of HSCs.   
They utilized a Bmi-1
-/- mouse model and showed that 
there was an increase in both p16
Ink4a and p19
Arf 
expression in HSCs leading to proliferation arrest and 
p53-dependent cell death.  The subsequent loss of 
p16
Ink4a expression in Bmi-1
-/- cells was able to partially 
rescue the self-renewal capacity of the stem cells [82, 
83].   
 
Bmi-1 is a Polycomb group (PcG) RING finger protein 
found to associate with the multiprotein PcG complex 
PRC1. PRC1 is a complex that maintains the repressive 
state of heterochromatin by modifying histone protein 
complexes.  It includes at least one paralogue of the 
Pcgf, Ring1, Phc and Cbx components as has been 
described [84].  PRC2 is the second complex that can 
associate with heterochromatin.  It is hypothesized that 
both PRC1 and PRC2 act in maintaining the 
heterochromatic structure necessary for stem cell self-
renewal and with age it is believed that these 
mechanisms become inadequate and can lead to 
neoplastic transformation of stem cell populations.  In 
ESCs mutant for PRC2, there is a loss in the ability to 
maintain an un-differentiated state of self-renewal [85, 
86].  Futhermore, both PRC1 and PRC2 have been 
shown to be inter-dependent in their effects on stem cell 
self-renewal and cancer development [87, 88].   
 
In similar studies, other PcG proteins have been found 
to affect the INK4a/ARF locus in aging stem cells.   
Jacobs and collegues show that Mel-18 and Cbx7 were 
found to regulate the INK4a/ARF locus [81].  Cbx7 is a 
PcG protein that helps form PRC1, this protein was 
independently found to extend the lifespan of primary 
human cell lines (Figure 2) [89].  When introduced into 
mouse fibroblasts, Cbx7 can result in immortalization of 
the cell line through the downregulation of the 
INK4a/ARF locus and interference with the p16
Ink4a/Rb 
and p19
Arf/p53 tumor suppressor pathways [89].   
 
The age-dependent decline in ASC self-renewing 
capacity has been associated with various 
transcriptional regulators other than the PcG proteins 
discussed above. 
 
Nishino and colleagues have recently discovered the 
involvement of Hmga2 in stem cell self-renewal [90].  
Hmga2 is a transcriptional regulator and was found to 
be highly expressed in young neural stem cell 
populations in mice.  Its expression declines with age 
and is believed to be regulated by the microRNA let-7b.  
Induced expression of let-7b in stem cells with high 
levels of Hmga2, showed a decrease in Hmga2 levels in 
concordance with a decreased ability for self-renewal.  
This corresponded to increased expression of p16
Ink4a 
and p19
Arf (Figure 2).  Furthermore, in mice deficient 
for Hmga2 there were reduced stem cell numbers and 
self-renewal throughout the central and peripheral 
nervous system of fetal and young-adult mice [90].  
 
Owing to the fact that the regulation of the ASC cell 
cycle is still not completely understood and because of 
the importance that the INK4a/ARF locus seems to play 
in aging ASCs, we performed a study on the senescence 
of rat MSCs in vitro looking specifically at the 
expression levels of Rb family proteins [91, 92].  We 
observed that the induction of senescence was 
associated with a decrease in expression of genes 
involved in stem cell self-renewal, DNA-damage repair 
genes, p107 and Rb/p105.  However, Rb2/p130 expres-
sion surprisingly increased during senescence in MSCs 
[92].  This suggested that Rb2/p130 plays a prominent 
role in either MSC specific aging and/or senescence.  It 
has previously been shown that Rb2/p130 can bind to 
   
www.impactaging.com                  377                                     AGING, April 2009, Vol.1 No.4HDAC1 repressing E2F-dependent gene expression, such 
as cyclin A, ultimately resulting in G0 growth arrest, 
supporting the possibility that Rb2/p130 has a more 
global role in cellular senescence (Figure 2) [92, 93].  
 
Over the past decade evidence has mounted in favor of 
the hypothesis that stem cell self-renewal is regulated 
through heterochromatin conformation under the 
control of PcG protein complexes.  This regulation 
appears to repress the INK4a/ARF locus, thus inhibiting  
the progression of tumor suppressive mechanisms such 
as senescence and apoptosis.  However, other regulatory 
mechanisms are present as seen with Hmga2, let-7b, 
and Rb2/p130, therefore the story is far from complete. 
The necessity for stem cells to maintain self-
renewability appears to be in balance with the risk to 
enter into un-controlled proliferation and possibly 
cancer.  Further studies are necessary to clarify how 








































The area of stem cell research is vastly and rapidly 
expanding with the hope of its potential in therapeutic 
applications.  In this review we have discussed the 
current characterizations and understandings of ESCs 
and ASCs.  ESCs have been utilized not only to 
understand development, but to obtain a manipulative 
system that could be applied towards regenerative and 
disease based therapies.  The first stem cell trial of this 
kind has just recently been approved by the Food and 
Drug Administration for Phase I clinical trial and is 
based upon the pre-clinical studies published in 2005 on 
hES cell-derived oligodendrocytes and their ability to 
remyelinate and restore function of the spinal chord in 
mice after injury [94]. This is the first example of a 
therapeutic potential that we have yet to reap and that 
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may help elucidate the ASC populations, which until 
now have been tedious to isolate and lack accurate and 
universal cell markers.  Here we have outlined the 
current understanding of ESC populations and their 
regulation of the cell cycle.  More importantly we 
highlight the significance of maintaining a self-
renewable population of ASCs and the regulation 
mechanisms that have been associated with this 
maintenance.  The pathway that appears to be involved 
across the board is the INK4a/ARF CDK-inhibitor 
pathway, which regulates the two major mechanisms of 
cell death, senescence and apoptosis.  Both p16
Ink4a and 
p19
Arf have been found to be un-detectable in young 
stem cell populations but increase in aging populations, 
lending to the importance of these pathways in stem cell 
maintenance.  As we have discussed, there are multiple 
genetic and epigenetic factors that appear to be 
associated with the INK4a/ARF pathway regulation in 
ASCs, speaking to the complexity and the profundity of 
what we have yet to ascertain. 
 
There is a cogent belief that organismal aging is linked 
to the aging and the loss of functional ASC populations.  
The data discussed here support the role of senescence 
and apoptosis as self-regulative mechanisms in aging 
ASCs.  Clarification and in-depth comprehension of 
these pathways may unveil needed therapeutic 
potentialities that could be applicative to both aging and 
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